Xencor (XNCR) News Today

Xencor, Inc. (NASDAQ:XNCR) shares have climbed after several analysts raised their Q3 2025 earnings forecasts, reflecting growing confidence in the biopharma’s upcoming results.

• Positive Sentiment: Leerink Partners lifted its Q3 EPS estimate to ($0.74) from ($0.76) and raised full-year 2025 and 2026 forecasts, signaling stronger profitability expectations. Leerink Partners Has Positive Forecast for Xencor Q3 Earnings
• Positive Sentiment: Wedbush boosted its Q3 EPS outlook to ($0.51) from ($0.79), reiterated an “Outperform” rating and set a $26 price target, highlighting robust near-term growth prospects. Wedbush Has Optimistic Outlook of Xencor Q3 Earnings
• Positive Sentiment: William Blair raised its Q3 EPS estimate to ($0.83) from ($0.89) and maintains an “Outperform” rating, underscoring confidence in Xencor’s financial trajectory. William Blair Analysts Boost Earnings Estimates for Xencor
• Neutral Sentiment: Short interest remains negligible with a days-to-cover ratio of 0.0, indicating minimal bearish bets against the stock.